| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2355 | 2020 |
| Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of … AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, O Degen, ... The Lancet 393 (10189), 2428-2438, 2019 | 1187 | 2019 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 845 | 2021 |
| Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two … B Clotet, N Bellos, JM Molina, D Cooper, JC Goffard, A Lazzarin, ... The Lancet 369 (9568), 1169-1178, 2007 | 618 | 2007 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 539 | 2021 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 444 | 2019 |
| Deep dermatophytosis and inherited CARD9 deficiency F Lanternier, S Pathan, QB Vincent, L Liu, S Cypowyj, C Prando, ... New England Journal of Medicine 369 (18), 1704-1714, 2013 | 398 | 2013 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 387 | 2021 |
| Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients M Remmelink, R De Mendonça, N D’Haene, S De Clercq, C Verocq, ... Critical care 24, 1-10, 2020 | 339 | 2020 |
| Early postmortem brain MRI findings in COVID-19 non-survivors T Coolen, V Lolli, N Sadeghi, A Rovai, N Trotta, FS Taccone, J Creteur, ... Neurology 95 (14), e2016-e2027, 2020 | 299 | 2020 |
| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 237 | 2013 |
| Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1 C Katlama, R Esposito, JM Gatell, JC Goffard, B Grinsztejn, A Pozniak, ... Aids 21 (4), 395-402, 2007 | 236 | 2007 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 191 | 2016 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 169 | 2022 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 119 | 2021 |
| Instant evaluation of the absolute initial number of cDNA copies from a single real‐time PCR curve S Swillens, JC Goffard, Y Marechal, A de Kerchove d’Exaerde, ... Nucleic acids research 32 (6), e56-e56, 2004 | 99 | 2004 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 91 | 2021 |
| COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... NIAID-USUHS/TAGC COVID Immunity Group, Inborn errors of type I IFN immunity …, 2020 | 86 | 2020 |
| Primary resistance to integrase strand-transfer inhibitors in Europe M Casadellà, PM Van Ham, M Noguera-Julian, A vAn Kessel, C Pou, ... Journal of antimicrobial chemotherapy 70 (10), 2885-2888, 2015 | 83 | 2015 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 370: eabd4570 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... | 81 | 2020 |
